期刊文献+

2017年英国国家健康与护理研究所成人帕金森病管理指南解读 被引量:4

Interpretation of 2017 British National Institute for Health and Care Excellence guideline: Parkinson's disease in adults
原文传递
导出
摘要 帕金森病是一种常见的神经系统慢性退行性疾病,目前尚无根治方法。帕金森病不仅给患者带来痛苦,同时给患者家庭及社会带来沉重负担,有效管理帕金森病迫在眉睫。2017年英国国家健康与护理研究所(NICE)发布了成人帕金森病管理指南。本文简要解读该指南对帕金森病的诊治建议,以期为国内帕金森病管理提供相关参考。 Parkinson's disease is a common chronic degenerative disease of the nervous system, which brings not only sufferings to patients, but also heavy burden to family and society. It is necessary to manage the Parkinson's disease effectively. In 2017, British National Institute for Health and Care Excellence published Parkinson's disease in adults: diagnosis and management. In order to explain the guideline briefly, this article provides an interpretation reference for the treatment of Parkinson's disease in China.
作者 李琳 刘振国 LI Lin;LIU Zhen-guo(Department of Neurology,Xinhua Hospital Affliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China)
出处 《世界临床药物》 CAS 2018年第7期441-444,共4页 World Clinical Drug
基金 国家重点研发计划"重大慢性非传染性疾病防控研究"重点专项(编号:2017YFC1310300)
关键词 帕金森病 指南 治疗 Parkinson's disease guideline treatment
  • 相关文献

参考文献2

二级参考文献45

  • 1Treatment of central nervous system degenerative disorders:Parkinson's disease.In:Brunton LL,Blumenthal D,Buxtun I,et al.Goodman's manual of pharmacology and therapeutics[M].NY:Mc Graw-Hill Professional,2007.
  • 2Rascal O,Goetz C,Koller W,et al.Treatment interventions for Parkinson's disease.An evidence based assessment[J].Lancet,2002,359(9317):1589-1598.
  • 3Lees A.Alternatives to levodopa in the initial treatment of early Parkinson's disease[J].Drugs Aging,2005,22(9):731-740.
  • 4Lees AJ.Drugs for Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2002,73(6):607-610.
  • 5Miyasaki JM,Martin W,Suchowersky O,et al.Practive parameter:initiation of treatment for Parkinson's disease:an evidence-based review:report of Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2002,58(1):11-17.
  • 6Koda-Kimble MA,Young LY,Aldredge BK,et al.Applied therapeutics.The Clinical Use of Drugs 9th ed.San Francisco[M].Calif:Lippincott Willians & Wikins,2008.
  • 7Koller WC,Tse W.Unmet medical need in Parkinson's disease[J].Neurol,2004,62(Suppy 1):S1-S8.
  • 8Oldfeld V,Keating GM,Perry CM.Sporlight on rasagiline in Parkinson's disease[J].CNS Drugs,2008,22(1):83-86.
  • 9Wesnes KA,McKeith I,Edgar C,et al.Bnefits of vivastigmine on attention in dementia associated with Pakinson disease[J].Neurology,2005,65(10):1654-1656.
  • 10Aarsland D,Ballard C,Walker Z,et al.Memantine in patiens with Pakinson's disease or dementia with Lewy bodies:a double-blind,placebo-controlled,multicense trial[J].Lancet Neurol,2009,8(7):613-618.

共引文献4

同被引文献48

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部